Annals of Hematology

, Volume 89, Issue 4, pp 421–422 | Cite as

Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report

  • Wan Kyu Eo
  • Se Hyun Kim
  • Seong Ha Cheon
  • Sang Hun Lee
  • Jong Soo Jeong
  • Yang Soo Kim
  • Hee Kyung Chang
  • Kee Suck Suh
  • Heung Yeol Kim
Letter to the Editor

References

  1. 1.
    Pereira FA, Mudgil AV, Rosmarin DM (2007) Toxic epidermal necrolysis. J Am Acad Dermatol 56:181–200. doi:10.1016/j.jaad.2006.04.048 CrossRefPubMedGoogle Scholar
  2. 2.
    Revuz J, Roujeau JC, Guillaume JC, Penso D, Touraine R (1987) Treatment of toxic epidermal necrolysis. Créteil's experience. Arch Dermatol 123:1156–1158. doi:10.1001/archderm.123.9.1156 CrossRefPubMedGoogle Scholar
  3. 3.
    Horowitz SB, Stirling AL (1999) Thalidomide-induced toxic epidermal necrolysis. Pharmacotherapy 19:1177–1180. doi:10.1592/phco.19.15.1177.30571 CrossRefPubMedGoogle Scholar
  4. 4.
    Rajkumar SV, Gertz MA, Witzig TE (2000) Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma. N Engl J Med 343:972–973. doi:10.1056/NEJM200009283431315 CrossRefPubMedGoogle Scholar
  5. 5.
    Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115:149–153. doi:10.1046/j.1523-1747.2000.00061.x CrossRefPubMedGoogle Scholar
  6. 6.
    Hall VC, El-Azhary RA, Bouwhuis S, Rajkumar SV (2003) Dermatologic side effects of thalidomide in patients with multiple myeloma. J Am Acad Dermatol 48:548–552. doi:10.1067/mjd.2003.87 CrossRefPubMedGoogle Scholar
  7. 7.
    Rajkumar SV, Hayman S, Gertz MA, Dispenzieri A, Lacy MQ, Greipp PR, Geyer S, Iturria N, Fonseca R, Lust JA, Kyle RA, Witzig TE (2002) Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma. J Clin Oncol 20:4319–4323. doi:10.1200/JCO.2002.02.116 CrossRefPubMedGoogle Scholar
  8. 8.
    Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, Mauri DN, Flynn K, Trent J, Margolis DJ, Saurat JH, French LE, TEN-IVIG Study Group (2003) Toxic epidermal necrolysis-intravenous immunoglobulin. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 139:26–32. doi:10.1001/archderm.139.1.26 CrossRefPubMedGoogle Scholar
  9. 9.
    Trent JT, Kirsner RS, Romanelli P, Kerdel FA (2003) Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience. Arch Dermatol 139:39–43. doi:10.1001/archderm.139.1.39 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Wan Kyu Eo
    • 1
    • 6
  • Se Hyun Kim
    • 7
  • Seong Ha Cheon
    • 1
  • Sang Hun Lee
    • 1
  • Jong Soo Jeong
    • 1
  • Yang Soo Kim
    • 2
  • Hee Kyung Chang
    • 3
  • Kee Suck Suh
    • 4
  • Heung Yeol Kim
    • 5
  1. 1.Integrative Cancer CenterKyung Hee University, East-West Neo Medical CenterSeoulSouth Korea
  2. 2.Department of Internal MedicineKosin University College of MedicineBusanSouth Korea
  3. 3.Department of PathologyKosin University College of MedicineBusanSouth Korea
  4. 4.Department of DermatologyKosin University College of MedicineBusanSouth Korea
  5. 5.Department of GynecologyKosin University College of MedicineBusanSouth Korea
  6. 6.Department of Internal Medicine, East-West Neo Medical CenterKyung Hee UniversitySeoulSouth Korea
  7. 7.Graduate School of East-West Medical ScienceKyung Hee UniversityYonginSouth Korea

Personalised recommendations